Velicept Therapeutics' Series C Round

Velicept Therapeutics raised a round of funding on July 18, 2018.

Velicept Therapeutics is a privately held, clinical development company focused on advancing best-in-class compounds with the potential to fill unmet medical needs.…

Articles about Velicept Therapeutics' Series C Round: